TABLE 1.
Demographic, Clinical, and Perioperative Data of Patients (N = 157)
| Age (y, mean ± SD) | 68.0 ± 11.1 |
| Gender, n (%) | |
| Male | 88 (56.1) |
| Female | 69 (43.9) |
| BMI (kg/m2, mean ± SD) | 237.7 ± 3.7 |
| ASA score, n (%) | |
| 1 | 4 (2.5) |
| 2 | 82 (52.3) |
| 3 | 69 (43.9) |
| 4 | 2 (1.3) |
| Diabetes, n (%) | |
| Yes | 26 (16.6) |
| No | 131 (83.4) |
| COPD, n (%) | |
| Yes | 5 (3.2) |
| No | 152 (96.8) |
| Smoking, n (%) | |
| Yes | 46 (29.3) |
| No | 111 (70.7) |
| Neoadjuvant CT, n (%) | |
| Yes | 31 (19.7) |
| No | 126 (80.3) |
| Neoadjuvant RT, n (%) | |
| Yes | 7 (4.5) |
| No | 150 (95.5) |
| Preoperative biliary drainage, n (%) | |
| Yes | 60 (38.2) |
| No | 97 (61.8) |
| Pancreatic texture, n (%) | |
| Hard | 82 (52.5) |
| Soft | 75 (47.8) |
| Main pancreatic duct diameter (mm, median, IQR) | 4.0 (2.0–5.5) |
| Risk class, n (%) | |
| Low | 79 (50.3) |
| Intermediate | 5 (3.2) |
| High | 73 (46.5) |
| Vascular resection, n (%) | |
| Yes | 51 (32.5) |
| No | 106 (67.5) |
| Blood losses (mL, median, IQR) | 400.0 (200.0–650.0) |
| Duration of procedure (min, median, IQR) | 240.0 (200.0–274.0) |
| POPF, n (%) | |
| Grade B POPF | 13 (8.3) |
| Grade C POPF | 12 (7.6) |
| Severe complications, n (%) | 26 (16.5) |
| Deaths, n (%) | 7 (4.5) |
| Length of stay (d, median, IQR) | 16.5 (14.0–21.0) |
ASA indicates American Society of Anesthesiologists physical status classification; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CT, chemotherapy; IQR, interquartile range; POPF, postoperative pancreatic fistula; RT, radiotherapy.